Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.46 |
| ▸ | GAPDH | P04406 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27204 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL19816345 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL15508284 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL11798450 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL28577636 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL16706242 | 1.00 | TSHR (0.67) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL10797175 | 0.98 | TSHR (0.64) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL6517013 | 0.98 | TSHR (0.64) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL21530621 | 0.96 | TSHR (0.60) | TSHRFAAHTRPV1FFAR4FFAR1 | |
| SCHEMBL7913952 | 0.92 | FFAR4 (0.55) | TSHRFAAHTRPV1FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018162450-A1 | NEW INMUNOSTIMULATORY COMPOSITIONS COMPRISING AN ENTITY OF COLD INDUCIBLE RNA-BINDING PROTEIN WITH AN ANTIGEN FOR THE ACTIVATION OF DENDRITIC CELLS | FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (ES) | 2018-09-13 | — | — | WO | disclosed |
| EP-2505640-A1 | Vaccine compositions for birnavirus-borne diseases | Neo Virnatech, S.L. (ES) | 2012-10-03 | — | — | EP | disclosed |
| CN-102325790-A | Use of phenol-soluble modulins for vaccine development | PROYECTO BIOMEDICINA CIMA SL | 2012-01-18 | — | — | CN | disclosed |
| US-20110268757-A1 | USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT | INSTITUT PASTEUR (FR) | 2011-11-03 | — | — | US | disclosed |
| EP-2374813-A1 | USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT | Proyecto de Biomedicina Cima, S.L. (ES) | 2011-10-12 | — | — | EP | disclosed |
| WO-2011101332-A1 | COMPOSITIONS BASED ON THE FIBRONECTIN EXTRACELLULAR DOMAIN A FOR THE TREATMENT OF MELANOMA | PROYECTO DE BIOMEDICINA CIMA, S.L. (ES) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268757-A1 | USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT | PSMB1, PSMG3, PSMD14 | TSHR 4672/4885FAAH 3478/4885TRPV1 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.